Muscle Invasive Bladder Carcinoma — Trials

Muscle Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 34
Recruiting: 22
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04610671	Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC	completed	Phase 1	21	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Feb 27, 2026	clinicaltrials
NCT05630131	ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy	completed	—	1	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Nov 28, 2025